Curated Indian Medicines & Active Salts Directory: "D" (23 Clinical Monographs)

PMBJP Jan Aushadhi Bioequivalence & Generic Cost Savings

The Government of India operates the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) to make high-quality generic medicines accessible to all citizens. Formulations supplied via Jan Aushadhi Kendras are produced in WHO-GMP certified facilities and tested at NABL-accredited laboratories for dissolution rate, purity, and plasma bioequivalence (80%–125% AUC confidence interval relative to innovator brands). Switching from high-cost branded formulations in section D to verified generic equivalents can reduce patient out-of-pocket healthcare expenses by 50% to 90% without compromising clinical outcomes.

Safe Dispensing & Patient Verification Checklist

• Verify that the active ingredient name and milligram strength match your physician's prescription.
• Never crush, chew, or split sustained-release (SR), extended-release (ER), or enteric-coated (EC) tablets.
• Inform your physician and pharmacist about all ongoing medications, dietary supplements, and herbal products.
• Check for known drug-food interactions (e.g., avoiding calcium/dairy with certain antibiotics, avoiding grapefruit with statins).
• Seek immediate emergency medical attention if you experience severe signs of drug allergy, such as hives, facial swelling, or breathing difficulty.

7. Pharmacovigilance & Substandard Drug Surveillance

Through the Pharmacovigilance Programme of India (PvPI), healthcare professionals and consumers can report unexpected adverse events or suspected spurious medical products directly to the National Coordination Centre at IPC Ghaziabad. Always purchase medicines in sealed, tamper-evident blister packaging from licensed retail chemists displaying an authentic drug licence number.

8. Pharmaceutical Nomenclature, INN Salts & Age-Specific Formulation Standards

In hospital and retail practice throughout India, pharmaceutical products starting with letter D adhere to naming rules regulated by the Indian Pharmacopoeia Commission (IPC). Clinical practitioners reference International Non-proprietary Names (INN) to identify active molecules, differentiate chemical salt forms (such as hydrochloride, sodium, potassium, maleate, mesylate, or tartrate salts), and evaluate physiological absorption rates. For pediatric and elderly patients, dosage formulation selection (liquid suspension, chewable tablet, dispersible tablet, or sustained-release capsule) must be carefully calibrated according to age-specific glomerular filtration capacity, hepatic metabolic clearance, and swallowing safety.

9. Clinical Verification & Pharmacovigilance Surveillance

All therapeutic data, active pharmaceutical ingredients, and dosage guidelines compiled under alphabetical section D are reviewed by the MediMatch Clinical Pharmacology Review Board in accordance with National Formulary of India (NFI) guidelines. Consumers are advised to always cross-check the batch manufacturing number, expiration date, and inner seal before consuming oral medications. For detailed brand monograph analysis and price comparisons, browse the verified clinical monographs indexed above or utilize the search bar to cross-reference therapeutic alternatives. Consult a registered physician or clinical pharmacist immediately if adverse symptoms develop.